← SynDRA
sotorasib
SynDRA canonical compound SYN0041214 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx |
|---|
| Primary target(s) | KRAS |
|---|
| Mechanism of action | ras gtpase inhibitor |
|---|
| Indication | non-small cell lung cancer (nsclc) |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- KRAS INHIBITOR
- ras gtpase inhibitor
Drug classes
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Immune Checkpoint Inhibitors
ATC classes
- OTHER ANTINEOPLASTIC AGENTS
Cross-references
Synonyms
- lumakras
- AMG510
- C30H30F2N6O3
- Lumakras (TN)
- AMG 510 racemate
- Sotorasib (JAN/USAN)
- AMG-510 (racemate)
- orb1298716
- SCHEMBL20805632
- SCHEMBL30008446
- HMS5087B10
- HMS5087J08
- MFCD32062763
- AKOS040759492
- SB23232
- SB40438
- AC-35180
- BA172506
- BP-43642
- T8684
- D12055
Look up sotorasib in the interactive SynDRA portal →